Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for SOPHiA GENETICS (SOPH) over the last 5 years, with Q3 2025 value amounting to $863000.0.

  • SOPHiA GENETICS's Change in Account Payables fell 3247.26% to $863000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 57446.81%. This contributed to the annual value of -$7.4 million for FY2024, which is 20748.07% down from last year.
  • SOPHiA GENETICS's Change in Account Payables amounted to $863000.0 in Q3 2025, which was down 3247.26% from $2.0 million recorded in Q2 2025.
  • SOPHiA GENETICS's Change in Account Payables' 5-year high stood at $6.0 million during Q3 2021, with a 5-year trough of -$4.1 million in Q1 2024.
  • In the last 4 years, SOPHiA GENETICS's Change in Account Payables had a median value of $869000.0 in 2021 and averaged $775153.8.
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 53430.66% in 2021, then tumbled by 29679.92% in 2024.
  • Over the past 4 years, SOPHiA GENETICS's Change in Account Payables (Quarter) stood at $869000.0 in 2021, then skyrocketed by 427.85% to $4.6 million in 2023, then plummeted by 155.88% to -$2.6 million in 2024, then skyrocketed by 133.67% to $863000.0 in 2025.
  • Its Change in Account Payables was $863000.0 in Q3 2025, compared to $2.0 million in Q2 2025 and $813000.0 in Q1 2025.